It will take some trial and error to determine which combination works best for you. There are a lot of combinations between the cycle settings and vacuum settings. You have the full range of the 12 levels in the expression setting.But, there is a strength of 320mmHg in the Spectra 2 and just 300mmHg in the S1. There are lighter options out there but it shouldn’t be too uncomfortable to carry around. In the massage mode, you can adjust it from L1 to L5 The at-home S2 model weighs 0.99kg and the portable S1 weighs 1.12kg.There are 12 levels for the strength of the suction.The massage or let-down setting is preset at 70 cycles and cannot be changed.+ to increase how frequently the pump cycles.The massage mode button, aka the let-down button, is right above the power button.The power button is color-coordinated with the pump color.There are seven buttons on the S1 and S2. The Expression setting is intended for after your milk lets down. SPECTRA S1 VS SPECTRA S2 The Spectra S1 has a rechargeable battery, which allows you to pump without access to an electrical outlet. is a weaker pump (only up to 260 mmHg) that’s not hospital-grade. is smaller (5 x 3 x 1.8 inches) weighs just 0.5 lbs. After that, you can enjoy up to 3 hours of pump time without having to recharge. You only need about 2-3 hours to charge up the battery on the Spectra S1. That is the only time the suction strength may differ. lasts up to 3 hours (2x Spectra S9’s battery power) Spectra S9. One thing to note is when comparing Spectra S1 vs S2 is that S1 has a decrease in suction when the battery is low. 27 patients in each arm received post-study chemotherapy including EGFR-TKIs (n=7/n=5), ALK-TKIs (n=0/n=3), and immune checkpoint inhibitors (n=6/n=10).The massage mode is a rapid cycle at a lower suction that simulates the way a baby sucks when they first latch on before your milk lets down. is heavier (2.42 lbs) is a hospital-grade pump that’s more powerful (up to 270 mmHg) has more customizable settings. After a median follow-up of 34.6 months, 44 OS events were observed. We know how hard it can be to find the perfect breast pump for yourself, especially when it comes to choosing between 2 reputable brands like Medela and. Objectives: SPECTRA is a multicenter, randomized phase II study of chemotherapy with cisplatin (CDDP) plus S-1 versus CDDP plus pemetrexed (PEM) in combination. Local relapse as the first site of failure was observed in 14 and 13 patients. 1 of Spectra S1 Plus Portable & Rechargeable Hospital Strength Double Electric Breast Pump - image 2 of Spectra S1 Plus Portable & Rechargeable Hospital. Distant metastases were the first site of failure in 24 and 31 patients. Disease progression was observed in 33 and 36 patients. A total of 72 PFS events were observed at the data cut-off (28 November 2018).
All 102 patients were eligible and assessable, of whom 52 were assigned to CDDP+S-1 and 50 to CDDP+PEM. Between Jan 2013 and Oct 2016, 102 patients were enrolled in this study from 9 institutions in Japan.
0 kommentar(er)
